Skip to main content Back to Top
Advertisement

5/29/2020

Levetiracetam Immediate-Release Tablets

Products Affected - Description

    • Keppra oral immediate release tablet, UCB, 1000 mg, bottle, 60 count, NDC 50474-0597-66
    • Keppra oral immediate release tablet, UCB, 750 mg, bottle, 120 count, NDC 50474-0597-40
    • Roweepra oral immediate release tablet, OWP, 1000 mg, bottle, 120 count, NDC 69102-0103-01
    • Roweepra oral immediate release tablet, OWP, 500 mg, bottle, 120 count, NDC 69102-0104-01
    • Roweepra oral immediate release tablet, OWP, 750 mg, bottle, 120 count, NDC 69102-0102-01
    • Levetiracetam oral immediate release tablet, Accord, 1000 mg, bottle, 60 count, NDC 16729-0067-12 - discontinued
    • Levetiracetam oral immediate release tablet, Accord, 250 mg, bottle, 120 count, NDC 16729-0064-29 - discontinued
    • Levetiracetam oral immediate release tablet, Lupin, 1000 mg, bottle, 60 count, NDC 68180-0115-07
    • Levetiracetam oral immediate release tablet, Lupin, 1000 mg, bottle, 500 count, NDC 68180-0115-02
    • Levetiracetam oral immediate release tablet, Lupin, 500 mg, bottle, 500 count, NDC 68180-0113-02
    • Levetiracetam oral immediate release tablet, Mylan, 1000 mg, unit-dose blister pack, 50 count, NDC 51079-0860-06 - discontinued
    • Levetiracetam oral immediate release tablet, Mylan, 250 mg, bottle, 120 count, NDC 00378-5613-78
    • Levetiracetam oral immediate release tablet, Mylan, 250 mg, bottle, 500 count, NDC 00378-5613-05
    • Levetiracetam oral immediate release tablet, Mylan, 250 mg, unit-dose blister pack, 100 count, NDC 51079-0820-20 - discontinued
    • Levetiracetam oral immediate release tablet, Mylan, 500 mg, bottle, 500 count, NDC 00378-5615-05
    • Levetiracetam oral immediate release tablet, Mylan, 750 mg, bottle, 500 count, NDC 00378-5617-05
    • Levetiracetam oral immediate release tablet, Mylan, 750 mg, unit-dose blister pack, 100 count, NDC 51079-0822-20 - discontinued
    • Levetiracetam oral immediate release tablet, Torrent, 1000 mg, bottle, 60 count, NDC 13668-0017-60
    • Levetiracetam oral immediate release tablet, Torrent, 1000 mg, bottle, 500 count, NDC 13668-0017-05
    • Levetiracetam oral immediate release tablet, Torrent, 250 mg, bottle, 250 count, NDC 13668-0014-25
    • Levetiracetam oral immediate release tablet, Torrent, 250 mg, bottle, 500 count, NDC 13668-0014-05
    • Levetiracetam oral immediate release tablet, Torrent, 500 mg, bottle, 250 count, NDC 13668-0015-25
    • Levetiracetam oral immediate release tablet, Torrent, 500 mg, bottle, 500 count, NDC 13668-0015-05
    • Levetiracetam oral immediate release tablet, Torrent, 750 mg, bottle, 250 count, NDC 13668-0016-25
    • Levetiracetam oral immediate release tablet, Torrent, 750 mg, bottle, 500 count, NDC 13668-0016-05

Reason for the Shortage

    • Accord discontinued levetiracetam immediate-release tablets.
    • Aurobindo refuses to provide availability information.
    • Camber did not provide a reason for the shortage.
    • Lupin did not provide a reason for the shortage.
    • Major has levetiracetam immediate-release tablets available.
    • Mylan did not provide a reason for the shortage.
    • OWP did not provide a reason for the Roweepra shortage.
    • Torrent did not provide a reason for the shortage.
    • UCB has Keppra immediate-release tablets available.

Available Products

    • Keppra oral immediate release tablet, UCB, 250 mg, bottle, 120 count, NDC 50474-0594-40
    • Keppra oral immediate release tablet, UCB, 500 mg, bottle, 120 count, NDC 50474-0595-40
    • Levetiracetam oral immediate release tablet, Camber, 1000 mg, bottle, 60 count, NDC 31722-0539-60
    • Levetiracetam oral immediate release tablet, Camber, 250 mg, bottle, 120 count, NDC 31722-0536-12
    • Levetiracetam oral immediate release tablet, Camber, 250 mg, bottle, 500 count, NDC 31722-0536-05
    • Levetiracetam oral immediate release tablet, Camber, 500 mg, bottle, 120 count, NDC 31722-0537-12
    • Levetiracetam oral immediate release tablet, Camber, 500 mg, bottle, 500 count, NDC 31722-0537-05
    • Levetiracetam oral immediate release tablet, Camber, 750 mg, bottle, 120 count, NDC 31722-0538-12
    • Levetiracetam oral immediate release tablet, Camber, 750 mg, bottle, 500 count, NDC 31722-0538-05
    • Levetiracetam oral immediate release tablet, Lupin, 250 mg, bottle, 90 count, NDC 68180-0112-09
    • Levetiracetam oral immediate release tablet, Lupin, 250 mg, bottle, 120 count, NDC 68180-0112-16
    • Levetiracetam oral immediate release tablet, Lupin, 250 mg, bottle, 500 count, NDC 68180-0112-02
    • Levetiracetam oral immediate release tablet, Lupin, 500 mg, bottle, 90 count, NDC 68180-0113-09
    • Levetiracetam oral immediate release tablet, Lupin, 500 mg, bottle, 120 count, NDC 68180-0113-16
    • Levetiracetam oral immediate release tablet, Lupin, 750 mg, bottle, 90 count, NDC 68180-0114-09
    • Levetiracetam oral immediate release tablet, Lupin, 750 mg, bottle, 500 count, NDC 68180-0114-02
    • Levetiracetam oral immediate release tablet, Major, 250 mg, bottle, 100 count, NDC 00904-6051-61
    • Levetiracetam oral immediate release tablet, Major, 500 mg, bottle, 100 count, NDC 00904-6052-61
    • Levetiracetam oral immediate release tablet, Major, 750 mg, bottle, 100 count, NDC 00904-6053-61
    • Levetiracetam oral immediate release tablet, Mylan, 1000 mg, bottle, 60 count, NDC 00378-5619-91
    • Levetiracetam oral immediate release tablet, Mylan, 500 mg, bottle, 120 count, NDC 00378-5615-78
    • Levetiracetam oral immediate release tablet, Mylan, 500 mg, unit-dose blister pack, 100 count, NDC 51079-0821-20
    • Levetiracetam oral immediate release tablet, Mylan, 750 mg, bottle, 120 count, NDC 00378-5617-78
    • Levetiracetam oral immediate release tablet, Torrent, 250 mg, bottle, 120 count, NDC 13668-0014-12
    • Levetiracetam oral immediate release tablet, Torrent, 500 mg, bottle, 120 count, NDC 13668-0015-12
    • Levetiracetam oral immediate release tablet, Torrent, 750 mg, bottle, 120 count, NDC 13668-0016-12

Estimated Resupply Dates

    • Lupin has levetiracetam 500 mg immediate-release tablets in 500 count on back order and the company cannot estimate a release date. The 1,000 mg immediate-release tablets in 60 and 500 count are on back order and the company cannot estimate a release date.
    • Mylan has levetiracetam 250 mg immediate-release tablets in 120 and 500 count bottles and 750 mg immediate-release tablets in 500 count bottles on back order and the company estimates release dates in late-June 2020. The 500 mg immediate-release tablets in 500 count bottles are on back order and the company estimates a release date of late-May 2020.
    • OWP has Roweepra immediate-release tablets on back order and the company cannot estimate a release date.
    • Torrent has levetiracetam 250 mg, 500 mg, and 750 mg immediate-release tablets in 250 and 500 count on back order and the company cannot estimate a release date. The 1,000 mg immediate-release tablets in 120 and 500 count are also on back order and the company cannot estimate a release date.
    • UCB has levetiracetam 750 mg immediate-release tablets in 120 count and 1,000 mg immediate-release tablets in 60 count on back order and the company cannot estimate a release date.

Updated

Updated May 29, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 22, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.